Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
cannabidiol
(BTX 1702) /
Botanix Pharma
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|
|||||||||
cannabidiol
(BTX 1702) /
Botanix Pharma
New P1 trial:
A Randomised, Double-Blind, Vehicle-Controlled Study of the Safety and Tolerability of BTX 1702 in Patients with Papulopustular Rosacea
(EUDRACT) - Aug 27, 2021
P1
, N=120, Not yet recruiting,
Sponsor: Botanix Pharmaceuticals Ltd